SPECIFIC MANAGEMENT OF MYASTHENIA GRAVIS IN PATIENTS UNDERGOING ABDOMINAL CANCER SURGERIES

21 clinical cases of abdominal cancer surgery in patients with concomitant myasthenia gravis are combined with the use of the “pharmacological duet” of rocuronium ‒ sugammadex and the mandatory monitoring of neuromuscular conduction. In all cases, surgery procedures were performed under combined ane...

Full description

Bibliographic Details
Main Authors: V. E. GRUZDEV, E. S. GOROBETS, V. V. KULАBUKHOV, А. А. MOROZOVА, M. А. АNISIMOV
Format: Article
Language:Russian
Published: New Terra Publishing House 2019-07-01
Series:Вестник анестезиологии и реаниматологии
Subjects:
Online Access:https://www.vair-journal.com/jour/article/view/336
_version_ 1797696866077376512
author V. E. GRUZDEV
E. S. GOROBETS
V. V. KULАBUKHOV
А. А. MOROZOVА
M. А. АNISIMOV
author_facet V. E. GRUZDEV
E. S. GOROBETS
V. V. KULАBUKHOV
А. А. MOROZOVА
M. А. АNISIMOV
author_sort V. E. GRUZDEV
collection DOAJ
description 21 clinical cases of abdominal cancer surgery in patients with concomitant myasthenia gravis are combined with the use of the “pharmacological duet” of rocuronium ‒ sugammadex and the mandatory monitoring of neuromuscular conduction. In all cases, surgery procedures were performed under combined anesthesia with sevoflurane and low-dose epidural ropivacaine + fentanyl + norepinephrine. In all cases, except one, when the mechanical ventilation was planned and determined by the severity of the operation, blood loss and hypothermia, it was possible to reliably restore the spontaneous breathing immediately after the end of the operation. The necessity of an individual approach to patients suffering from myasthenia gravis, due to the difference in its severity and degree of compensation, is clearly shown. It was especially emphasized that with subcompensated state, incomplete efficacy of sugammadex is possible and additional intravenous administration of anticholinesterase drugs may be required (2 cases). In addition, in severe myasthenia gravis, a discrepancy is possible between “safe” TOF = 90% and clinical signs of residual respiratory failure (1 case).
first_indexed 2024-03-12T03:32:19Z
format Article
id doaj.art-eb4647410d724e96a751caf2a29f8cd4
institution Directory Open Access Journal
issn 2078-5658
2541-8653
language Russian
last_indexed 2024-03-12T03:32:19Z
publishDate 2019-07-01
publisher New Terra Publishing House
record_format Article
series Вестник анестезиологии и реаниматологии
spelling doaj.art-eb4647410d724e96a751caf2a29f8cd42023-09-03T13:24:41ZrusNew Terra Publishing HouseВестник анестезиологии и реаниматологии2078-56582541-86532019-07-01163485410.21292/2078-5658-2019-16-3-48-54315SPECIFIC MANAGEMENT OF MYASTHENIA GRAVIS IN PATIENTS UNDERGOING ABDOMINAL CANCER SURGERIESV. E. GRUZDEV0E. S. GOROBETS1V. V. KULАBUKHOV2А. А. MOROZOVА3M. А. АNISIMOV4ФГБУ «НМИЦ им. Н. Н. Блохина» МЗ РФФГБУ «НМИЦ им. Н. Н. Блохина» МЗ РФФГБУ «НМИЦ им. Н. Н. Блохина» МЗ РФФГБУ «НМИЦ им. Н. Н. Блохина» МЗ РФФГБУ «НМИЦ им. Н. Н. Блохина» МЗ РФ21 clinical cases of abdominal cancer surgery in patients with concomitant myasthenia gravis are combined with the use of the “pharmacological duet” of rocuronium ‒ sugammadex and the mandatory monitoring of neuromuscular conduction. In all cases, surgery procedures were performed under combined anesthesia with sevoflurane and low-dose epidural ropivacaine + fentanyl + norepinephrine. In all cases, except one, when the mechanical ventilation was planned and determined by the severity of the operation, blood loss and hypothermia, it was possible to reliably restore the spontaneous breathing immediately after the end of the operation. The necessity of an individual approach to patients suffering from myasthenia gravis, due to the difference in its severity and degree of compensation, is clearly shown. It was especially emphasized that with subcompensated state, incomplete efficacy of sugammadex is possible and additional intravenous administration of anticholinesterase drugs may be required (2 cases). In addition, in severe myasthenia gravis, a discrepancy is possible between “safe” TOF = 90% and clinical signs of residual respiratory failure (1 case).https://www.vair-journal.com/jour/article/view/336myasthenia gravisполостные операциирокуронийсугаммадексtof мониторингантихолинэстеразные препараты
spellingShingle V. E. GRUZDEV
E. S. GOROBETS
V. V. KULАBUKHOV
А. А. MOROZOVА
M. А. АNISIMOV
SPECIFIC MANAGEMENT OF MYASTHENIA GRAVIS IN PATIENTS UNDERGOING ABDOMINAL CANCER SURGERIES
Вестник анестезиологии и реаниматологии
myasthenia gravis
полостные операции
рокуроний
сугаммадекс
tof мониторинг
антихолинэстеразные препараты
title SPECIFIC MANAGEMENT OF MYASTHENIA GRAVIS IN PATIENTS UNDERGOING ABDOMINAL CANCER SURGERIES
title_full SPECIFIC MANAGEMENT OF MYASTHENIA GRAVIS IN PATIENTS UNDERGOING ABDOMINAL CANCER SURGERIES
title_fullStr SPECIFIC MANAGEMENT OF MYASTHENIA GRAVIS IN PATIENTS UNDERGOING ABDOMINAL CANCER SURGERIES
title_full_unstemmed SPECIFIC MANAGEMENT OF MYASTHENIA GRAVIS IN PATIENTS UNDERGOING ABDOMINAL CANCER SURGERIES
title_short SPECIFIC MANAGEMENT OF MYASTHENIA GRAVIS IN PATIENTS UNDERGOING ABDOMINAL CANCER SURGERIES
title_sort specific management of myasthenia gravis in patients undergoing abdominal cancer surgeries
topic myasthenia gravis
полостные операции
рокуроний
сугаммадекс
tof мониторинг
антихолинэстеразные препараты
url https://www.vair-journal.com/jour/article/view/336
work_keys_str_mv AT vegruzdev specificmanagementofmyastheniagravisinpatientsundergoingabdominalcancersurgeries
AT esgorobets specificmanagementofmyastheniagravisinpatientsundergoingabdominalcancersurgeries
AT vvkulabukhov specificmanagementofmyastheniagravisinpatientsundergoingabdominalcancersurgeries
AT aamorozova specificmanagementofmyastheniagravisinpatientsundergoingabdominalcancersurgeries
AT maanisimov specificmanagementofmyastheniagravisinpatientsundergoingabdominalcancersurgeries